NorthEdge to float Accrol on AIM
NorthEdge Capital has announced its intention to float tissue products supplier Accrol on AIM on 10 June.
Accrol has a 35 per cent market share of the discount market and seven...
NorthEdge Capital has announced its intention to float tissue products supplier Accrol on AIM on 10 June.
Accrol has a 35 per cent market share of the discount market and seven...